Title : Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.

Pub. Date : 2010

PMID : 21182350






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER. Darunavir CD4 molecule Homo sapiens
2 CONCLUSIONS: Darunavir-based HAART may lower non-antiretroviral-related costs compared with control PI-based therapy in highly treatment-experienced, HIV-infected patients during the first year of therapy by improving patients" CD4 cell counts. Darunavir CD4 molecule Homo sapiens